The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 340.00
Bid: 341.00
Ask: 349.00
Change: -17.00 (-4.76%)
Spread: 8.00 (2.346%)
Open: 347.00
High: 349.00
Low: 338.00
Prev. Close: 357.00
APTD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of RevStream

31 Aug 2017 07:00

RNS Number : 3757P
Microgen PLC
31 August 2017
 

microgen

www.microgen.com 31 August 2017

 

 

 

ACQUISITION OF REVSTREAM INC.

Microgen plc ('Microgen') is pleased to announce the acquisition of RevStream Inc. ('RevStream'), a California-based provider of revenue management enterprise software. The acquisition broadens and complements the specialist capabilities within Microgen's Aptitude Software business ('Aptitude') and provides access to RevStream's growing client base in the technology sector.

RevStream will be integrated into Aptitude which already has an established office in Boston and a strong North American presence with over 50% of H1 2017 Aptitude revenues generated in the US and Canada.

Since 2015 Aptitude has established a market leading position in the telecommunications sector with the Aptitude Revenue Recognition Engine ('ARRE'), an application which enables organisations to address the requirements of IFRS 15 and ASC 606. ARRE has established this strong position as a result of its capability to process very rapidly a very high volume of complex, business event-driven transactions and calculations. The acquisition of RevStream enables Aptitude to offer broader revenue management functionality which augments the specialised capabilities of ARRE.

RevStream's growing client base, primarily focussed on the technology sector, complements Aptitude's strong presence within the financial services, insurance and telecommunications sectors and provides cross-selling opportunities for both organisations' products. In addition, RevStream's existing cloud capabilities will be leveraged across Aptitude's new applications where cloud deployment is appropriate.

Consideration for the entire issued and to be issued shares of RevStream is £9.7 million. In addition, at completion RevStream had debt and debt-like items of £2.5 million which Microgen will settle under its ownership. Of the consideration of £9.7 million, £7.7 million is expected to be payable in cash of which approximately 70% was paid on completion with the remaining 30% payable across the following two-year period. The initial cash consideration was satisfied using Microgen's existing cash resources. The consideration of £9.7 million also includes 421,582 Microgen shares (valued at £2.0 million as at 30 August 2017) which will be issued in August 2019. The founder, CEO and former majority shareholder of RevStream, Rajiv Chopra, will remain with the business.

RevStream has experienced a significant increase in demand for its products and services in 2017. RevStream's on-going recurring revenue base is currently £2.9 million, an increase of 58% since 31 December 2016, with a number of further opportunities well progressed. RevStream's revenue in the year ended 31 December 2016 was £2.7 million; this is expected to more than double in 2017. RevStream reported a loss before tax in 2016 of £0.8 million. The gross assets at 31 December 2016 were £0.9 million. The acquisition of RevStream is anticipated to be earnings enhancing in 2018.

 

Contacts

Philip Wood, Chief Financial Officer 020-7496-8100

 

James Melville-Ross / Darius Alexander 020-3727-1000

FTI Consulting

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQGUGDIIBXBGRB
Date   Source Headline
28th Jul 20237:00 amRNSHolding(s) in Company
27th Jul 20231:52 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSInterim Results
24th Jul 20235:22 pmRNSHolding(s) in Company
20th Jul 20237:00 amRNSHolding(s) in Company
19th Jul 20237:00 amRNSDirector Retirement
13th Jul 20237:00 amRNSTrading Update and Directorate Changes
23rd Jun 20234:43 pmRNSHolding(s) in Company
16th Jun 20234:22 pmRNSHolding(s) in Company
25th May 20235:22 pmRNSDirector/PDMR Shareholding
24th May 202311:01 amRNSHolding(s) in Company
23rd May 20236:10 pmRNSDirector/PDMR Shareholding
23rd May 20233:27 pmRNSHolding(s) in Company
17th May 202311:24 amRNSResult of AGM
17th May 20237:00 amRNSAGM Statement and Appointment of CFO
2nd May 202311:44 amRNSHolding(s) in Company
24th Apr 20235:13 pmRNSExercise of awards under 2020 Deferred Bonus Plan
20th Apr 202311:30 amRNSGrant of awards under 2020 Deferred Bonus Plan
17th Apr 202311:49 amRNSHolding(s) in Company
17th Apr 20238:32 amRNSHolding(s) in Company
29th Mar 20234:36 pmRNSDirector/PDMR Shareholding
29th Mar 20234:35 pmRNSPrice Monitoring Extension
29th Mar 202311:27 amRNSBLOCK LISTING SIX MONTHLY RETURN
21st Mar 20237:00 amRNSAudited Results for Year Ended 31 December 2022
13th Feb 20235:20 pmRNSHolding(s) in Company
1st Feb 20234:40 pmRNSSecond Price Monitoring Extn
1st Feb 20234:35 pmRNSPrice Monitoring Extension
26th Jan 20237:00 amRNSHolding(s) in Company
24th Jan 20237:00 amRNSFull Year Trading Update and Directorate Change
12th Jan 20239:51 amRNSNew Directorship Notification
24th Nov 20227:00 amRNSGrant of awards under Performance Share Plan
8th Nov 20227:00 amRNSGrant of awards
21st Oct 20224:41 pmRNSSecond Price Monitoring Extn
21st Oct 20224:36 pmRNSPrice Monitoring Extension
28th Sep 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
28th Jul 20227:00 amRNSInterim Results
18th Jul 20227:00 amRNSNotice of Results
31st May 202211:40 amRNSTotal Voting Rights
26th May 20228:56 amRNSHolding(s) in Company
17th May 20221:57 pmRNSDirector/PDMR Shareholding and Total Voting Rights
5th May 20222:10 pmRNSDirector Shareholding
29th Apr 202210:56 amRNSTotal Voting Rights
28th Apr 202212:24 pmRNSResult of AGM and Directorate Change
28th Apr 20227:00 amRNSAGM Statement
12th Apr 202211:50 amRNSBlock Listing Application
11th Apr 20222:30 pmRNSBlock listing Interim Review
4th Apr 20227:00 amRNSGrant of awards under 2020 Deferred Bonus Plan
22nd Mar 20227:00 amRNSDirector/PDMR Shareholding
15th Mar 20227:00 amRNSAudited Preliminary Results
1st Mar 20221:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.